Palbociclib in Real World Practice

Completed

Conditions studied: Advanced Breast Cancer, Metastatic Breast Cancer

In brief

This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.

Key facts

Study ID

NCT03280303

Run by

Pfizer

People needed

1285

Starts

2017-01-04

Expected to finish

2022-12-22

Last updated by the study team

2024-09-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years or older.
• Diagnosis of adenocarcinoma of the breast with evidence of metastatic disease or advanced disease not amenable to treatment with curative intent.
• Documented HR+ (ER+ and/or PR+) tumor based on local standards.
• Documented HER2- tumor based on local standards.
• Physician has determined that treatment with palbociclib is indicated.
• Evidence of a personally signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the study.
• Patients who in the opinion of the investigator are willing and able to comply with regular clinic visits as per standard of care practice at the site.

You may not qualify if…

• Patients with a life expectancy of less than 3 months at the time of ABC diagnosis, per the investigator's judgment.
• Patients participating in any interventional clinical trial that includes investigational or marketed products at the time of enrollment. (Patients participating in other investigator initiated research or NIS can be included as long as their standard of care is not altered by the study).
• Patients on active treatment for malignancies other than ABC at the time of enrollment.
• Patients who are unable to understand the nature of the study and are unwilling to sign an informed consent.

Where it is running

• Alabama Oncology — Bessemer, Alabama, United States
• Alabama Oncology — Birmingham, Alabama, United States
• Alabama Oncology — Birmingham, Alabama, United States
• Alabama Oncology — Birmingham, Alabama, United States
• Alabama Oncology — Birmingham, Alabama, United States
• Grandview Cancer Center, Alabama Oncology — Birmingham, Alabama, United States
• University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama, United States
• The University of Alabama at Birmingham — Birmingham, Alabama, United States
• Central Arkansas Radiation Therapy Institute — Little Rock, Arkansas, United States
• Central Arkansas Radiation Therapy Institute — Stuttgart, Arkansas, United States
• Sutter Auburn — Auburn, California, United States
• AIS Cancer Center at Adventist Health Bakersfield — Bakersfield, California, United States
• Beverly Hills Cancer Center — Beverly Hills, California, United States
• Providence Health and Services Southern California — Burbank, California, United States
• Enloe Regional Cancer Center — Chico, California, United States
• John Muir Clinical Research Center — Concord, California, United States
• John Muir Medical Center, Concord Campus — Concord, California, United States
• Mount Diablo Solano Oncology Group — Concord, California, United States
• Global Cancer Research Institute, Inc. — Gilroy, California, United States
• Breastlink Medical Group, Inc. — Laguna Hills, California, United States
• Breastlink Medical Group, Inc. — Newport Beach, California, United States
• Breastlink Medical Group, Inc. — Orange, California, United States
• St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare — Petaluma, California, United States
• Diablo Valley Oncology Hematology Medical Group — Pleasant Hill, California, United States
• Alabama Oncology — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.